BLUME-JENSEN PETER (President and CEO) reported 1 transaction at ACRIVON THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/26/2026ACC: 0000905148-26-002652
DirectorOfficer· President and CEO
Since Mar 2026
-13.73K
Net shares
Net seller
$24.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
13.73K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−13.73K
Price / share
$1.79
Trade value
$24.57K
% of position
0.6%
5/21/2026
2.26M→2.25M
Total
Net shares
−13.73K
Net value
-$24.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2026 | F · Tax Withholding | −13.73K | $1.79 | $24.57K | 0.6% | 2.26M | 2.25M |
| Total | −13.73K | -$24.57K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned386.34K
Total
386.34K indirect386.34K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 386.34K | Indirect |
| Total | 386.34K | 386.34K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported